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Resistance to chemotherapy drugs is an issue faced in cancer treatment.  Only some of the 
causes of drug resistance are known, and further study is needed in order to improve the 
efficacy of existing drugs and to develop new drugs.  Previous studies have shown that the 
protein complex PP4C controls sensitivity to the commonly used drug cisplatin both in human 
cells and in the model organism Dictyostelium discoideum.  Other signaling proteins have been 
linked to PP4C in the developmental pathways of Dictyostelium.  Our goal was to determine if 
these proteins are involved in controlling sensitivity to cisplatin.   
To standardize the results when calculating cell survival after drug treatment, a new method of 
analysis was developed.  The effect of drug treatment is usually calculated by dividing the 
average value of surviving cisplatin-treated cells by the average value of surviving untreated 
cells to find percent survival.  In the new calculation method, the growth of an individual 
cisplatin-treated sample is divided by the average growth of the untreated samples to determine 
the percent survival.  An advantage to the new calculation method is that the initial number of 
cells in each flask does not need to be the same. Cells of Dictyostelium mutants lacking the 
specific signaling proteins were treated with cisplatin, and cell survival was measured.  The 
survival of the cisplatin-treated mutants was compared to the survival of the similarly treated 
parent strains.  Deleting these genes in Dictyostelium has a low but consistent effect on cisplatin 
sensitivity.  The results suggest that modulation of the proteins may be useful in increasing the 
sensitivity of cancer cells to drug treatment and may be employed in chemotherapy. 
 
